COVID-19 Diagnostics - Global Market Outlook (2020-2027)

16800
Present Value (M$)
2020
31180
Forecast Value (M$)
2027
9.2%
CAGR (%)

According to Stratistics MRC, the Global COVID-19 Diagnostics Market is accounted for $16.80 billion in 2020 and is expected to reach $31.18 billion by 2027 growing at a CAGR of 9.2% during the forecast period.

Main companies

  • Alveo Technologies
  • Accelerate Diagnostics
  • Abbott Diagnostics
  • Aus Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Applied BioCode
  • BD Diagnostics
  • Cue Health
  • Biocartis
  • Co-Diagnostics
  • BioFire Diagnostics
  • Cepheid
  • bioMerieux
  • Bosch Healthcare Solutions GmbH
  • Bio-Rad Laboratories
  • Curetis
  • GenePOC Diagnostics
  • Diagenode Diagnostics
  • GenMark Dx